Yes. All three options are available across a wide age range. SLIT is generally available starting at age 5, OIT from around age 4 and up, and Xolair from age 1. Adult patients are equally eligible and benefit from all three treatments.
FAQs
The right treatment depends on your specific allergen(s), the severity of your allergy, your age, your lifestyle, and your goals. Your board-certified FCAAC allergist will evaluate all of these factors at your consultation and make a personalized recommendation. Some patients may be candidates for more than one option.
In some cases, yes. Xolair is sometimes used in combination with OIT to improve safety during the build-up phase, particularly in highly sensitive patients. Your allergist will determine whether combination therapy is appropriate for you.
Patients who have had difficulty completing OIT at another practice may still be candidates at FCAAC. We offer individualized protocols and, in appropriate cases, may consider Xolair to facilitate a safer OIT build-up. Please share your prior treatment history at your consultation.
If none of the three current treatment options is right for you at this time, your FCAAC allergist will still provide comprehensive food allergy management — including updated action plans, epinephrine prescription guidance, and monitoring. We will continue to evaluate your candidacy as your situation evolves and as new treatments become available.
Yes. All three options are available across a wide age range. SLIT is generally available starting at age 5, OIT from around age 4 and up, and Xolair from age 1. Adult patients are equally eligible and benefit from all three treatments.